GLP-1 therapies

WASHINGTON, April 8, 2026 Vanda Pharmaceuticals Inc. has announced the initiation of the Thetis clinical trial evaluating NEREUS™ (tradipitant)...

Jupiter, Florida | January 28, 2026 — Jupiter Neurosciences, Inc., a clinical-stage pharmaceutical company, announced a strategic expansion of...

Vancouver, BC – December 8, 2025 – TempraMed Technologies Ltd. has announced a strategic commercial agreement with Maccabi Healthcare...